These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34405778)

  • 1. Expedited Antitrust Review of COVID-19-Related Requests.
    Lu VJ
    Am J Law Med; 2021 Jul; 47(2-3):341-350. PubMed ID: 34405778
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-Market Mergers in Healthcare: Adapting Antitrust Regulation to Address a Growing Concern.
    Lopatka TJ
    Cornell Law Rev; 2017 Apr; 102(3):821-52. PubMed ID: 28379657
    [No Abstract]   [Full Text] [Related]  

  • 3. The stifling of competition by the antitrust laws: the irony of the health care industry.
    Powers JA
    J Law Health; 2000-2001; 15(2):223-46. PubMed ID: 12238323
    [No Abstract]   [Full Text] [Related]  

  • 4. Health care and the federal antitrust laws: the likelihood of a harmonious coexistence.
    Remis RE
    J Contemp Health Law Policy; 1996; 13(1):113-35. PubMed ID: 9068239
    [No Abstract]   [Full Text] [Related]  

  • 5. Accountable Care Organizations and Antitrust Enforcement: Promoting Competition and Innovation.
    Feinstein DL; Kuhlmann P; Mucchetti PJ
    J Health Polit Policy Law; 2015 Aug; 40(4):875-86. PubMed ID: 26124309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lost World: Discovering Medical Antitrust Law's Uses and Abuses.
    McClarey D
    J Leg Med; 2017; 37(3-4):541-558. PubMed ID: 29473811
    [No Abstract]   [Full Text] [Related]  

  • 7. Competition policy in health care markets: navigating the enforcement and policy maze.
    Gaynor M
    Health Aff (Millwood); 2014 Jun; 33(6):1088-93. PubMed ID: 24841882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striking out! Federal enforcers losing streak in antitrust cases shows need for new game plan.
    Hallam K
    Mod Healthc; 1998 Apr; 28(17):30-3. PubMed ID: 10179159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical care. Antitrust laws emerging exemption.
    Troupis JR
    Benders Health Care Law Mon; 1997 Jul; ():3-10. PubMed ID: 10173326
    [No Abstract]   [Full Text] [Related]  

  • 10. Assembled Products: The Key to More Effective Competition And Antitrust Oversight in Health Care.
    Sage WM
    Cornell Law Rev; 2016; 101(3):609-700. PubMed ID: 27062731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accrediting and the Sherman Act.
    Havighurst CC; Brody PM
    Law Contemp Probl; 1994; 57(4):199-242. PubMed ID: 10140660
    [No Abstract]   [Full Text] [Related]  

  • 12. Senate subcommittee to probe GPO influence.
    DeJohn P
    Hosp Mater Manage; 2001 Aug; 26(8):1, 10-1. PubMed ID: 11499225
    [No Abstract]   [Full Text] [Related]  

  • 13. Masimo wins new round. Tyco unit plans appeal of dollar 420 million antitrust verdict.
    Becker C
    Mod Healthc; 2005 Mar; 35(13):17. PubMed ID: 15807093
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitrust watchdog. FTC Chairman Majoras says healthcare remains an important priority for her agency.
    Taylor M
    Mod Healthc; 2006 Jun; 36(26):28-30. PubMed ID: 16841649
    [No Abstract]   [Full Text] [Related]  

  • 15. Higher standard. Ruling could make it tougher for antitrust plaintiffs.
    Evans M
    Mod Healthc; 2007 May; 37(22):14-5. PubMed ID: 17612023
    [No Abstract]   [Full Text] [Related]  

  • 16. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
    Whitener MD
    Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care as a (big) business: the antitrust response.
    Havighurst CC
    J Health Polit Policy Law; 2001 Oct; 26(5):939-55. PubMed ID: 11765273
    [No Abstract]   [Full Text] [Related]  

  • 18. Addressing Consolidation in Health Care Markets.
    Dafny L
    JAMA; 2021 Mar; 325(10):927-928. PubMed ID: 33507224
    [No Abstract]   [Full Text] [Related]  

  • 19. Physician networks and their implications for competition in health care markets.
    Haas-Wilson D; Gaynor M
    Health Econ; 1998 Mar; 7(2):179-82. PubMed ID: 9565176
    [No Abstract]   [Full Text] [Related]  

  • 20. Market therapy. Competition can be messy and expensive, but it benefits the patient.
    Burda D
    Mod Healthc; 2008 Mar; 38(13):19. PubMed ID: 18467989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.